Francesca Urbani

Istituto Superiore di Sanità — Italy

Immunology and Microbiology · Life Sciences

24h-index2.8kcitations78works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(22), Immunotherapy and Immune Responses(21), Reproductive System and Pregnancy(13), Cancer Immunotherapy and Biomarkers(9), Bacterial Infections and Vaccines(9)

Publications78 total

T Cell Peptide Prediction, Immune Response, and Host–Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects
Biomolecules·2024· 2 citedOpen Access
Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC)
Vaccines·2024· 3 citedOpen Access
Optimization and intra-assay validation of a multiparametric flow cytometric test for monitoring circulating TREGs
Methods in cell biology·2024
Update on virus-induced asthma exacerbations
Expert Review of Clinical Immunology·2023· 15 cited
Eosinophils as potential biomarkers in respiratory viral infections
Frontiers in Immunology·2023· 45 citedOpen Access
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alpha
Frontiers in Oncology·2023· 3 citedOpen Access
Supplementary Table 3 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure Legend from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Data from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 3 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Methods from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure Legend from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Table 1 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
Supplementary Figure 2 from Cyclophosphamide Induces a Type I Interferon–Associated Sterile Inflammatory Response Signature in Cancer Patients' Blood Cells: Implications for Cancer Chemoimmunotherapy
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Clara Maria Ausiello(23), Filippo Belardelli(14), Antonio Cassone(13), Roberto Lande(10), Iole Macchia(9), Enrico Proietti(7), Carla Buccione(6), Luciano Castiello(6), Andrea Sala(5), Fabio Malavasi(5), Federica Moschella(5), Valentina La Sorsa(4), Imerio Capone(4), Ada Funaro(4), Beatrice Di Carlo(4), Giorgio Fedele(4), Antonella Torosantucci(4), Eleonora Aricò(4), Paola Rizza(4), Laura Bracci(3)